NAD(+) improves cognitive function and reduces neuroinflammation by ameliorating mitochondrial damage and decreasing ROS production in chronic cerebral hypoperfusion models through Sirt1/PGC-1α pathway

BACKGROUND: Microglial-mediated neuroinflammation plays an important role in vascular dementia, and modulating neuroinflammation has emerged as a promising treatment target. Nicotinamide adenine dinucleotide (NAD(+)) shows anti-inflammatory and anti-oxidant effects in many neurodegenerative disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yao, Zhang, Jiawei, Zheng, Yaling, Zhang, Yaxuan, Zhang, Xiao Jie, Wang, Hongmei, Du, Yu, Guan, Jian, Wang, Xiuzhe, Fu, Jianliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444613/
https://www.ncbi.nlm.nih.gov/pubmed/34530866
http://dx.doi.org/10.1186/s12974-021-02250-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444613/
https://www.ncbi.nlm.nih.gov/pubmed/34530866
http://dx.doi.org/10.1186/s12974-021-02250-8

Ejemplares similares